CLASS II Device recall · Reported 20 Feb 2019 · FDA Enforcement Report

Stationary Fluoroscopic X-ray System CombiDiagnost R90 recalled

Philips Medical Systems Gmbh, DMC is recalling Stationary Fluoroscopic X-ray System CombiDiagnost R90, distributed nationwide in the US. The recall was initiated on 7 Nov 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll CombiDiagnost systems with software version 1.0.0, 1.0.1 and 1.0.2
Quantity recalled146

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0612-2019
FDA event ID
81706
Recalling firm
Philips Medical Systems Gmbh, DMC, Hamburg, N/A
Classification
Class II
Status
Terminated
Recall initiated
7 Nov 2018
FDA classified
12 Feb 2019
Reported
20 Feb 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

7 Nov 2018Recall initiated by company
12 Feb 2019Classified by FDA+97 days
20 Feb 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

kV/mA lockin not functioning as specified which may result in the patient receiving an increased radiation dose.

Product as listed by the FDA

Stationary Fluoroscopic X-ray System CombiDiagnost R90, Model 709030 Stationary Fluoroscopic X-ray System

Where it was distributed

Worldwide Distribution: US (nationwide) to states of: AZ, CA, GA, IL, MN, MO, MT, NJ, OH, TX, UT & VA; and to countries of: Australia, Austria, Bangladesh, Belgium, Chile C¿te D'Ivoire, Czech Republic. Egypt, Ethiopia, France, Germany, Ghana, Iran, Italy, Jordan, Latvia, Lebanon, Luxembourg, Malaysia, Martinique, Mexico, Nepal, Netherlands, New Zealand, Philippines, Portugal Russian Federation, Rwanda, Saudi Arabia, Serbia, South Africa, Spain, Switzerland, Turkey, United Arab Emirates and United Kingdom.

Nationwide ArizonaCaliforniaGeorgiaIllinoisMinnesotaMissouriMontanaNew JerseyOhioTexasUtahVirginia

Questions about this recall

Why was it recalled?

kV/mA lockin not functioning as specified which may result in the patient receiving an increased radiation dose.

Which lots are affected?

All CombiDiagnost systems with software version 1.0.0, 1.0.1 and 1.0.2

Where was it sold?

Worldwide Distribution: US (nationwide) to states of: AZ, CA, GA, IL, MN, MO, MT, NJ, OH, TX, UT & VA; and to countries of: Australia, Austria, Bangladesh, Belgium, Chile C¿te D'Ivoire, Czech Republic. Egypt, Ethiopia, France, Germany, Ghana, Iran, Italy, Jordan, Latvia, Lebanon, Luxembourg, Malaysia, Martinique, Mexico, Nepal, Netherlands, New Zealand, Philippines, Portugal Russian Federation, Rwanda, Saudi Arabia, Serbia, South Africa, Spain, Switzerland, Turkey, United Arab Emirates and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Medical Systems Gmbh, DMC

All 33

Other Imaging Equipment recalls

All 2,336